FibroGen, Inc. (FGEN)
USD 0.3
(8.19%)
USD 0.3
(8.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 128.9 Million USD | 7.02% |
| 2022 | 120.45 Million USD | -45.85% |
| 2021 | 222.43 Million USD | 32.84% |
| 2020 | 167.45 Million USD | -34.44% |
| 2019 | 255.43 Million USD | 1216.34% |
| 2018 | -22.88 Million USD | 67.7% |
| 2017 | -70.84 Million USD | -828.68% |
| 2016 | -7.62 Million USD | 77.06% |
| 2015 | -33.26 Million USD | -152.11% |
| 2014 | -13.19 Million USD | -180.15% |
| 2013 | 16.46 Million USD | 298.58% |
| 2012 | -8.28 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 30.14 Million USD | 38.74% |
| 2024 Q2 | 45.46 Million USD | 50.79% |
| 2023 Q3 | 35.89 Million USD | -7.04% |
| 2023 Q4 | 21.73 Million USD | -39.45% |
| 2023 FY | 128.9 Million USD | 7.02% |
| 2023 Q1 | 32.67 Million USD | 10.96% |
| 2023 Q2 | 38.61 Million USD | 18.18% |
| 2022 Q4 | 29.44 Million USD | 157.65% |
| 2022 Q3 | 11.42 Million USD | -50.31% |
| 2022 Q2 | 22.99 Million USD | -59.36% |
| 2022 Q1 | 56.58 Million USD | 321.74% |
| 2022 FY | 120.45 Million USD | -45.85% |
| 2021 Q2 | 21.28 Million USD | -39.23% |
| 2021 Q3 | 152.7 Million USD | 617.41% |
| 2021 Q4 | 13.41 Million USD | -91.21% |
| 2021 FY | 222.43 Million USD | 32.84% |
| 2021 Q1 | 35.02 Million USD | -43.85% |
| 2020 Q2 | 39.81 Million USD | 69.91% |
| 2020 Q3 | 41.82 Million USD | 5.06% |
| 2020 Q4 | 62.38 Million USD | 49.15% |
| 2020 FY | 167.45 Million USD | -34.44% |
| 2020 Q1 | 23.43 Million USD | 231.46% |
| 2019 Q1 | -26.63 Million USD | -170.51% |
| 2019 FY | 255.43 Million USD | 1216.34% |
| 2019 Q4 | 7.06 Million USD | -78.53% |
| 2019 Q3 | 32.93 Million USD | -76.4% |
| 2019 Q2 | 139.55 Million USD | 624.0% |
| 2018 Q1 | -25.04 Million USD | -151.52% |
| 2018 Q2 | -8.18 Million USD | 67.32% |
| 2018 FY | -22.88 Million USD | 67.7% |
| 2018 Q4 | 37.77 Million USD | 237.77% |
| 2018 Q3 | -27.41 Million USD | -234.91% |
| 2017 Q4 | -9.95 Million USD | 56.82% |
| 2017 FY | -70.84 Million USD | -828.68% |
| 2017 Q1 | -19.84 Million USD | -6.13% |
| 2017 Q2 | -17.98 Million USD | 9.36% |
| 2017 Q3 | -23.06 Million USD | -28.25% |
| 2016 Q3 | -10.45 Million USD | -128.35% |
| 2016 FY | -7.62 Million USD | 77.06% |
| 2016 Q4 | -18.69 Million USD | -78.8% |
| 2016 Q1 | -15.36 Million USD | 56.69% |
| 2016 Q2 | 36.88 Million USD | 340.03% |
| 2015 Q2 | 68.99 Million USD | 301.5% |
| 2015 Q1 | -34.24 Million USD | 2.59% |
| 2015 FY | -33.26 Million USD | -152.11% |
| 2015 Q4 | -35.48 Million USD | -9.06% |
| 2015 Q3 | -32.53 Million USD | -147.15% |
| 2014 Q4 | -35.15 Million USD | -30.41% |
| 2014 Q3 | -26.95 Million USD | -147.55% |
| 2014 Q1 | -7.77 Million USD | 54.39% |
| 2014 Q2 | 56.68 Million USD | 829.21% |
| 2014 FY | -13.19 Million USD | -180.15% |
| 2013 FY | 16.46 Million USD | 298.58% |
| 2013 Q4 | -17.04 Million USD | -135.46% |
| 2013 Q3 | 48.06 Million USD | 2164.6% |
| 2013 Q2 | -2.32 Million USD | 80.97% |
| 2013 Q1 | -12.23 Million USD | 0.0% |
| 2012 FY | -8.28 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | 7.672% |
| Immix Biopharma, Inc. | -5468.00 USD | 2357525.018% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 19513.253% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 266.118% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 24559.962% |
| MiMedx Group, Inc. | 266.84 Million USD | 51.693% |
| Novavax, Inc. | 639.93 Million USD | 79.857% |
| Seer, Inc. | 7.02 Million USD | -1734.41% |
| Acelyrin, Inc. | -115 Thousand USD | 112190.435% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 4.705% |
| IO Biotech, Inc. | -756 Thousand USD | 17150.794% |
| Ardelyx, Inc. | 106.66 Million USD | -20.854% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 232.959% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 513.583% |
| Fortress Biotech, Inc. | 57.85 Million USD | -122.813% |
| Fortress Biotech, Inc. | 57.85 Million USD | -122.813% |
| Geron Corporation | -123.5 Million USD | 204.373% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 46.454% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -677.608% |
| Incyte Corporation | 3.44 Billion USD | 96.253% |
| Innoviva, Inc. | 261.06 Million USD | 50.624% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 234470.909% |
| ChromaDex Corporation | 50.78 Million USD | -153.848% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -7.642% |
| MEI Pharma, Inc. | 49.32 Million USD | -161.325% |
| NextCure, Inc. | -3.68 Million USD | 3599.023% |
| Onconetix, Inc. | -1.12 Million USD | 11536.125% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 544.988% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 90053.315% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 221.467% |
| Vaxcyte, Inc. | -75 Million USD | 271.872% |
| Precigen, Inc. | 106 Thousand USD | -121507.547% |
| Pharming Group N.V. | 220.1 Million USD | 41.435% |
| ContextLogic Inc. | 59 Million USD | -118.481% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 55662.069% |
| Pyxis Oncology, Inc. | -2 Million USD | 6545.2% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -17.429% |
| AlloVir, Inc. | -398 Thousand USD | 32487.94% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -343.655% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1282599.254% |
| Summit Therapeutics Inc. | -2.05 Million USD | 6388.0% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1074300.0% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 22675.131% |
| Senti Biosciences, Inc. | -2.68 Million USD | 4904.473% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -107320.0% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2786.619% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -342.528% |
| Psyence Biomedical Ltd. | -240.00 USD | 53710100.0% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 291817.208% |
| Chimerix, Inc. | 324 Thousand USD | -39685.185% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 224961.319% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 157300.0% |
| CRISPR Therapeutics AG | 240.95 Million USD | 46.503% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -23.828% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -24929.903% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -12675.421% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3591.441% |
| Precision BioSciences, Inc. | 40.47 Million USD | -218.502% |
| Dyadic International, Inc. | 922.95 Thousand USD | -13866.414% |
| Elevation Oncology, Inc. | -39 Thousand USD | 330623.077% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -512.051% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -6.997% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 91.508% |
| Aptorum Group Limited | -1.11 Million USD | 11664.133% |
| Bicycle Therapeutics plc | -129.52 Million USD | 199.524% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3369.975% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1537.708% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1065.006% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 90.623% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2844.358% |
| Jaguar Health, Inc. | 7.72 Million USD | -1568.876% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -25888.71% |
| AbCellera Biologics Inc. | 38.02 Million USD | -238.998% |
| PureTech Health plc | -1.6 Million USD | 8141.422% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 25045.331% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 384.399% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -15972.818% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -498.301% |
| AnaptysBio, Inc. | 14.78 Million USD | -772.093% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 662.433% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 108888.009% |
| Molecular Templates, Inc. | 50.39 Million USD | -155.787% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -338.643% |
| Vaxxinity, Inc. | -2.23 Million USD | 5870.098% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 26300.0% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 686.274% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 375.207% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 13680.65% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2578180.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3082.029% |
| ImmuCell Corporation | 4.39 Million USD | -2832.113% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 73825.571% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -30301.887% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -576.91% |
| Opthea Limited | 21.72 Thousand USD | -593380.663% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 171.058% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 231.244% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 231.316% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -21066.502% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 58.905% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -4907.925% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 254148.088% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1916.061% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 27263.704% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1239561.538% |
| Soligenix, Inc. | 97.31 Thousand USD | -132366.011% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1292.562% |
| Kura Oncology, Inc. | -849 Thousand USD | 15283.039% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 292.096% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 87789.796% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -30.155% |
| Autolus Therapeutics plc | -4.86 Million USD | 2748.531% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -211.468% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 76828.571% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -36.085% |
| GRI Bio, Inc. | 10.84 Million USD | -1089.042% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -4974.989% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1583.872% |
| IGM Biosciences, Inc. | -211.66 Million USD | 160.901% |
| INmune Bio, Inc. | 155 Thousand USD | -83063.871% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -108.114% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 8657.709% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 19978.665% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 440436.134% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -31965.672% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 6558.116% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 41283.387% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -36.463% |
| Verastem, Inc. | -62 Thousand USD | 208009.677% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -5193.799% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 49488.506% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -4158.474% |
| Histogen Inc. | 3.76 Million USD | -3320.111% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -22272.214% |
| Surrozen, Inc. | -27.23 Million USD | 573.39% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2491.984% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 10798.493% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 602.608% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -542.849% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 6510403.03% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2024.877% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 192118.591% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 16.724% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -88311.523% |
| Apollomics, Inc. | 127 Thousand USD | -101399.213% |
| Amarin Corporation plc | 165.54 Million USD | 22.132% |
| Mesoblast Limited | -9.81 Million USD | 1413.337% |
| Turnstone Biologics Corp. | 16.5 Million USD | -680.952% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 216.667% |
| Synaptogenix, Inc. | -6347.00 USD | 2031043.753% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 252852.941% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 20.117% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 92.666% |
| Better Therapeutics, Inc. | -2.72 Million USD | 4823.488% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 214.928% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 61.872% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1130043.899% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2159.169% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 11733.935% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1661.465% |
| Insmed Incorporated | 239.63 Million USD | 46.208% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -3502.683% |
| OmniAb, Inc. | 14.66 Million USD | -778.871% |
| Alector, Inc. | -95.05 Million USD | 235.613% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -2.613% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 396.583% |
| Zai Lab Limited | 170.9 Million USD | 24.575% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -57.436% |
| Aura Biosciences, Inc. | -1.29 Million USD | 10053.977% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -99056.923% |
| Immunic, Inc. | -111 Thousand USD | 116229.73% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -713.069% |
| Veracyte, Inc. | 248.14 Million USD | 48.054% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.844% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 22855419.149% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1204.871% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.207% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -33037.275% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 63.724% |
| TG Therapeutics, Inc. | 219.1 Million USD | 41.169% |
| Galecto, Inc. | -830 Thousand USD | 15630.602% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 9407.148% |
| Fortrea Holdings Inc. | 424 Million USD | 69.598% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 249.598% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 22834.392% |
| XBiotech Inc. | -1.74 Million USD | 7491.284% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 11733.935% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 377.386% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 270.657% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -75.611% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -667.149% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 66.866% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 359.641% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 60.55% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1238.342% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -427.193% |
| NexImmune, Inc. | -1.02 Million USD | 12676.344% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2387011.111% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1914.104% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.859% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 192992.095% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3730.076% |
| Ainos, Inc. | -253.73 Thousand USD | 50903.009% |
| Pluri Inc. | 322 Thousand USD | -39932.298% |
| Prothena Corporation plc | -129.2 Million USD | 199.77% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -155.64% |
| Celularity Inc. | 6.75 Million USD | -1808.275% |
| Rallybio Corporation | -150 Thousand USD | 86036.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 495.326% |
| MeiraGTx Holdings plc | 287 Thousand USD | -44814.286% |
| Omeros Corporation | -69.77 Million USD | 284.732% |
| Humacyte, Inc. | -76.55 Million USD | 268.392% |
| Immunocore Holdings plc | 248.39 Million USD | 48.104% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 949.786% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -106.637% |
| Blueprint Medicines Corporation | 236.58 Million USD | 45.514% |
| CalciMedica, Inc. | -58 Thousand USD | 222348.276% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 9139.551% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 4632.489% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 517.638% |
| Pulmatrix, Inc. | -8.22 Million USD | 1668.175% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 11117.436% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 32406.767% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 132.323% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4544.21% |
| Cytokinetics, Incorporated | -322.59 Million USD | 139.959% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -14852.239% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 37901.76% |
| Vor Biopharma Inc. | -3.49 Million USD | 3791.409% |
| Roivant Sciences Ltd. | 109.23 Million USD | -18.006% |
| Evogene Ltd. | 1.39 Million USD | -9114.01% |
| ProKidney Corp. | -3.16 Million USD | 4167.655% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 393.551% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1779.889% |
| CorMedix Inc. | -205.56 Thousand USD | 62808.088% |
| BioLineRx Ltd. | 1.1 Million USD | -11533.935% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 263.852% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 390718.182% |
| Atai Life Sciences N.V. | -5000.00 USD | 2578180.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 105881.272% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 134375.0% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 9380.346% |
| Sagimet Biosciences Inc. | 2 Million USD | -6345.2% |
| MediciNova, Inc. | 979.7 Thousand USD | -13057.43% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 252.877% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 136427.005% |
| GeoVax Labs, Inc. | -20.72 Million USD | 722.101% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 47.286% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3168.412% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 85.223% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1635.847% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 41681.935% |
| Absci Corporation | -41.84 Million USD | 408.022% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2578180.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 268.782% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 5337.871% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 39.69% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 13798.618% |
| Allakos Inc. | -6.14 Million USD | 2199.072% |
| Imunon, Inc. | -720 Thousand USD | 18003.209% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 286.828% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 72.913% |
| BioAtla, Inc. | -103.73 Million USD | 224.268% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1130043.899% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 72517.978% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 153.086% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 41548.232% |
| XOMA Corporation | 3.86 Million USD | -3238.617% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 283.925% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -771.326% |
| aTyr Pharma, Inc. | -2.38 Million USD | 5497.99% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -934.543% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 444596.552% |
| Viridian Therapeutics, Inc. | -1 Million USD | 12888.095% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -991569130.769% |
| Akari Therapeutics, Plc | -4000.00 USD | 3222700.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 79.76% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -66103.751% |
| UroGen Pharma Ltd. | 73.35 Million USD | -75.733% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 582.895% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1110184.238% |
| Orgenesis Inc. | -5.72 Million USD | 2351.598% |
| Entera Bio Ltd. | -56 Thousand USD | 230285.714% |
| GH Research PLC | -315 Thousand USD | 41021.905% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 68303.175% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 24653.143% |
| Xencor, Inc. | -85.26 Million USD | 251.189% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 58433.673% |
| Replimune Group, Inc. | -2.65 Million USD | 4955.141% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 12974.487% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 27.518% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -66103.751% |
| Portage Biotech Inc. | -54 Thousand USD | 238811.111% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 136427.005% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 34292.042% |
| OncoCyte Corporation | 413 Thousand USD | -31111.622% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2867819.689% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 58064964.865% |
| Purple Biotech Ltd. | -196 Thousand USD | 65867.347% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1337.377% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1217.767% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1334.127% |
| HilleVax, Inc. | -2.15 Million USD | 6078.85% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 132990.722% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 859230.898% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 19397.006% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 560552.174% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1717409.516% |
| Savara Inc. | -44.26 Million USD | 391.229% |
| Curis, Inc. | 9.81 Million USD | -1213.872% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4554.377% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 103398.394% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 7555.408% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 56636.842% |
| BeiGene, Ltd. | 2.07 Billion USD | 93.799% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 4710.465% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 132.253% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -127.392% |
| Erasca, Inc. | -3.73 Million USD | 3554.019% |
| bluebird bio, Inc. | -4.03 Million USD | 3298.61% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 456914.799% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 93.231% |
| DBV Technologies S.A. | 15.72 Million USD | -719.583% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 456914.799% |
| Moderna, Inc. | 2.15 Billion USD | 94.018% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 14187.869% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1510.092% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 24149.254% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 3.651% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2171.745% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 427.642% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 215.996% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3692.642% |
| MacroGenics, Inc. | 50.52 Million USD | -155.119% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2213.873% |
| Prime Medicine, Inc. | -147.9 Million USD | 187.153% |
| Aditxt, Inc. | -111.66 Thousand USD | 115543.31% |
| Adagene Inc. | 18.11 Million USD | -611.725% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -26314.754% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 8.058% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 18.33% |
| SciSparc Ltd. | 2.19 Million USD | -5769.945% |
| Vericel Corporation | 135.57 Million USD | 4.921% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 514707.37% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 416160.939% |
| Generation Bio Co. | -73.91 Million USD | 274.404% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 29597.483% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -136.006% |
| Invivyd, Inc. | -2.02 Million USD | 6456.213% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 142.848% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 124719.579% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -33.762% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -31.149% |
| ADMA Biologics, Inc. | 88.21 Million USD | -46.12% |
| Clene Inc. | 533 Thousand USD | -24084.615% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -434.668% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 13569.592% |
| GeoVax Labs, Inc. | -20.72 Million USD | 722.101% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -6384.105% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 66437.306% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -158.817% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1917.597% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 15519.139% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -54.533% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -176210.318% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -142.474% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 174.43% |
| Trevena, Inc. | 1.45 Million USD | -8759.381% |
| Surrozen, Inc. | -27.23 Million USD | 573.39% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 36616.714% |
| Cingulate Inc. | -582.91 Thousand USD | 22213.573% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 415919.355% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 754.368% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1702926.948% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 14731.555% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 81.063% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 13146.964% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 228888.47% |
| Kronos Bio, Inc. | 1.37 Million USD | -9295.335% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 340.197% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 44245.205% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 26497.769% |
| ImmunityBio, Inc. | -17.89 Million USD | 820.537% |
| Korro Bio, Inc. | -3.63 Million USD | 3651.074% |
| Kineta, Inc. | 5.43 Million USD | -2272.612% |
| BioVie Inc. | -229.37 Thousand USD | 56297.439% |
| Codexis, Inc. | 57.33 Million USD | -124.83% |
| Celularity Inc. | 6.75 Million USD | -1808.275% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3112.16% |
| Celcuity Inc. | -142.77 Thousand USD | 90386.611% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -254701.344% |
| Cibus, Inc. | 1.42 Million USD | -8964.979% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 34566.31% |
| IN8bio, Inc. | -2.5 Million USD | 5254.098% |
| Kodiak Sciences Inc. | -25.94 Million USD | 596.797% |
| Annexon, Inc. | -3.26 Million USD | 4045.638% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 6406.458% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 408.848% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -20041.25% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 83.442% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 25.47% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 6884.421% |
| Arcellx, Inc. | 108.27 Million USD | -19.048% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 498.233% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -62.749% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 709.418% |
| Moolec Science SA | -143.3 Thousand USD | 90050.804% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 404.608% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3821.631% |
| Royalty Pharma plc | 1.79 Billion USD | 92.814% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 283.912% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3568870.764% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -55608.303% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 215.698% |
| Humacyte, Inc. | -76.55 Million USD | 268.392% |
| 89bio, Inc. | -273 Thousand USD | 47317.582% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 10354.893% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 15300.943% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 104900.0% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -11419.571% |
| Notable Labs, Ltd. | 113 Thousand USD | -113974.336% |
| Liquidia Corporation | 14.6 Million USD | -782.904% |
| Mustang Bio, Inc. | -2.22 Million USD | 5893.438% |
| Immunovant, Inc. | -231 Thousand USD | 55902.597% |
| Quantum-Si incorporated | 488 Thousand USD | -26314.754% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 332.013% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 429780.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -6822.879% |
| Acasti Pharma Inc. | -11 Thousand USD | 1171954.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 63097.698% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 19978.665% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 176.952% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -11261.385% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 33933.071% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 6683.453% |
| PepGen Inc. | -1.18 Million USD | 10987.162% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 101599.213% |
| United Therapeutics Corporation | 2.07 Billion USD | 93.773% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 662.973% |
| Solid Biosciences Inc. | -76.56 Million USD | 268.363% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 156190.236% |
| Immuneering Corporation | -764.13 Thousand USD | 16969.204% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -194430.967% |
| Belite Bio, Inc | -399 Thousand USD | 32406.767% |
| XOMA Corporation | 3.86 Million USD | -3238.617% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 743.362% |
| Bionomics Limited | -434.44 Thousand USD | 29770.686% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 12102.235% |
| uniQure N.V. | 2.21 Million USD | -5719.594% |
| Cassava Sciences, Inc. | -89.42 Million USD | 244.151% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 240.008% |
| Forte Biosciences, Inc. | -9000.00 USD | 1432366.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 15537.605% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 29597.483% |
| Altimmune, Inc. | -65.37 Million USD | 297.182% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 64.394% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 12102.235% |
| Compugen Ltd. | 31.45 Million USD | -309.804% |
| Peak Bio, Inc. | 367.76 Thousand USD | -34950.263% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -425.795% |
| Benitec Biopharma Inc. | 108 Thousand USD | -119255.556% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 165361.538% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 10815.212% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 7174.863% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 108422.689% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 10815.212% |
| Instil Bio, Inc. | -4.75 Million USD | 2810.345% |
| argenx SE | 1.1 Billion USD | 88.371% |
| Immunome, Inc. | -8.9 Million USD | 1547.221% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 6920.317% |
| Verona Pharma plc | -679.62 Thousand USD | 19066.958% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 73759.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 5504.78% |
| CervoMed Inc. | -1.29 Million USD | 10064.542% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5455.38% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2798.43% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -5116.673% |
| Moolec Science SA | -143.3 Thousand USD | 90050.804% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 31691.795% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 4925.104% |
| Design Therapeutics, Inc. | -537 Thousand USD | 24104.469% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 30288.29% |
| NeurAxis, Inc. | 2.15 Million USD | -5876.898% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -5906.71% |
| Lumos Pharma, Inc. | 2 Million USD | -6322.72% |
| Achilles Therapeutics plc | -4.73 Million USD | 2824.513% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 73759.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 122081.547% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -307.167% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -14852.239% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 12590.698% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 383.007% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -299676.744% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 15781.752% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 979762.563% |
| Palisade Bio, Inc. | 246 Thousand USD | -52300.0% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 390718.182% |
| Beam Therapeutics Inc. | -59.67 Million USD | 316.021% |
| Neurogene Inc. | -3.26 Million USD | 4051.686% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 7.486% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -222.26% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 43502.02% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3300.964% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1447.522% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -815.511% |
| Athira Pharma, Inc. | -969 Thousand USD | 13402.786% |
| Vaccinex, Inc. | -16 Million USD | 905.449% |
| HCW Biologics Inc. | -574.82 Thousand USD | 22524.951% |
| XOMA Corporation | 3.86 Million USD | -3238.617% |
| Nektar Therapeutics | 53.47 Million USD | -141.041% |
| Arvinas, Inc. | 71.8 Million USD | -79.532% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 254.448% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 305.343% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 40132.298% |
| Rezolute, Inc. | -36 Thousand USD | 358166.667% |
| Clene Inc. | 533 Thousand USD | -24084.615% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 10039352.336% |
| BeyondSpring Inc. | 1.75 Million USD | -7261.736% |
| Synlogic, Inc. | -1.92 Million USD | 6799.792% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 348489.189% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2135.755% |
| Peak Bio, Inc. | 367.76 Thousand USD | -34950.263% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 779.766% |
| Krystal Biotech, Inc. | 47.6 Million USD | -170.778% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 8.638% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2465.254% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 5078.49% |
| MannKind Corporation | 136.19 Million USD | 5.351% |
| Ikena Oncology, Inc. | -50.49 Million USD | 355.296% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -18.463% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3039.658% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 51252.381% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2578180.0% |
| Legend Biotech Corporation | 140.92 Million USD | 8.533% |
| Mural Oncology plc | -2.56 Million USD | 5121.582% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 23494.555% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 129004.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -521.104% |
| REGENXBIO Inc. | 53.02 Million USD | -143.082% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2506.293% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 67106.628% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 7542.494% |
| Vaxart, Inc. | -60.76 Million USD | 312.142% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 49153.961% |
| Cellectis S.A. | 18 Thousand USD | -716033.333% |
| Longeveron Inc. | 221 Thousand USD | -58227.602% |
| Repare Therapeutics Inc. | -80.07 Million USD | 260.989% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 88.206% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 10061.669% |
| Revolution Medicines, Inc. | -399.66 Million USD | 132.253% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 368397.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -262969.388% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.502% |
| Denali Therapeutics Inc. | -93.34 Million USD | 238.094% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 514707.37% |
| Veru Inc. | 7.56 Million USD | -1603.743% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 85466.887% |
| Cingulate Inc. | -582.91 Thousand USD | 22213.573% |
| Passage Bio, Inc. | -3.72 Million USD | 3564.23% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1070375.656% |
| Exicure, Inc. | -1.42 Million USD | 9158.609% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 33756.397% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -4668.923% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 25243.414% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -89.214% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 86261.744% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 317.721% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -32867.775% |
| OmniAb, Inc. | 14.66 Million USD | -778.871% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -544.746% |
| Lipocine Inc. | -2.85 Million USD | 4621.65% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 7094.249% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2359.492% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 8657.709% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -71.151% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 198413.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -52.918% |
| Ocugen, Inc. | -33.53 Million USD | 484.364% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 4176.66% |
| Q32 Bio Inc. | 578 Thousand USD | -22201.73% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 48743.019% |
| Alumis Inc. Common Stock | -1.28 Million USD | 10139.252% |
| Equillium, Inc. | 35.95 Million USD | -258.485% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 7651.494% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -25645.837% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3118242.235% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 49869.884% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -30394.521% |
| Dominari Holdings Inc. | 2.03 Million USD | -6221.923% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 70358.515% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1048.172% |
| Bio-Techne Corporation | 773.07 Million USD | 83.326% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -644.292% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 72.025% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 11126.861% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 637.548% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1002.026% |
| Nkarta, Inc. | -5.86 Million USD | 2296.354% |
| BioCardia, Inc. | -7.24 Million USD | 1878.231% |
| Iterum Therapeutics plc | -1.75 Million USD | 7465.943% |